Company

Nucleus Genomics

Consumer genomics platform offering whole-genome sequencing, polygenic risk scores, and embryo genetic analysis to make personalized medicine accessible

Healthcare & Biotech

People

Kian Sadeghifounder, ceo

Funding History

Jan 31, 2025Series A

Nucleus Genomics raised a $14M Series A with participation from Founders Fund, 776, Neo, Balaji Srinivasan, and others to expand its full-genome sequencing consumer platform.

14M

Investors

Serena VenturesFounders FundNeo

News

Interviews (3)

Nucleus Genomics launches embryo IQ and disease screening — the world's first consumer genetic optimization software for IVF
4 Jun 2025
Kian Sadeghi of Nucleus Genomics on replacing 23andMe with true whole-genome sequencing
24 Mar 2025
Nucleus Genomics launches genetic matchmaking: screen 1,000 conditions, find a compatible partner
14 Mar 2025

News (1)

Nucleus Genomics raises $14M Series A to build next-gen consumer genomics platform
30 Jan 2025